TY - JOUR
T1 - Paediatric systemic lupus erythematosus as a manifestation of constitutional mismatch repair deficiency
AU - Toledano, Helen
AU - Orenstein, Naama
AU - Sofrin, Efrat
AU - Ruhrman-Shahar, Noa
AU - Amarilyo, Gil
AU - Basel-Salmon, Lina
AU - Shuldiner, Alan R.
AU - Smirin-Yosef, Pola
AU - Aronson, Melyssa
AU - Al-Tarrah, Hibs
AU - Bazak, Lili
AU - Gonzaga-Jauregui, Claudia
AU - Tabori, Uri
AU - Wimmer, Katharina
AU - Goldberg, Yael
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2020/7/1
Y1 - 2020/7/1
N2 - Biallelic mutations in any of the four mismatch repair genes MSH2, MSH6, MLH1 and PMS2 result in one of the most aggressive childhood cancer predisposition syndromes, termed constitutional mismatch repair deficiency (CMMRD) syndrome. In addition to a very high tumour risk, the CMMRD phenotype is often characterised by the presence of signs reminiscent of neurofibromatosis type 1. Although paediatric systemic lupus erythematosus (pSLE) has been reported so far in three patients with CMMRD, it has not been considered a diagnostic feature of the syndrome. We report here two additional female patients with pSLE and CMMRD due to biallelic pathogenic variants in MSH6. Hence, there are a total of five out of approximately 200 (2.5%) currently reported patients with CMMRD that also have pSLE, suggesting pSLE should raise the suspicion of a diagnosis of CMMRD, especially if supported by additional indicative features.
AB - Biallelic mutations in any of the four mismatch repair genes MSH2, MSH6, MLH1 and PMS2 result in one of the most aggressive childhood cancer predisposition syndromes, termed constitutional mismatch repair deficiency (CMMRD) syndrome. In addition to a very high tumour risk, the CMMRD phenotype is often characterised by the presence of signs reminiscent of neurofibromatosis type 1. Although paediatric systemic lupus erythematosus (pSLE) has been reported so far in three patients with CMMRD, it has not been considered a diagnostic feature of the syndrome. We report here two additional female patients with pSLE and CMMRD due to biallelic pathogenic variants in MSH6. Hence, there are a total of five out of approximately 200 (2.5%) currently reported patients with CMMRD that also have pSLE, suggesting pSLE should raise the suspicion of a diagnosis of CMMRD, especially if supported by additional indicative features.
KW - CMMRD
KW - Lynch
KW - MSH6
KW - SLE
UR - http://www.scopus.com/inward/record.url?scp=85072217423&partnerID=8YFLogxK
U2 - 10.1136/jmedgenet-2019-106303
DO - 10.1136/jmedgenet-2019-106303
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 31501241
AN - SCOPUS:85072217423
SN - 0022-2593
VL - 57
SP - 505
EP - 508
JO - Journal of Medical Genetics
JF - Journal of Medical Genetics
IS - 7
ER -